| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c06d114257182ee7efd4c696c5fdb836 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401 |
| filingDate |
1993-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2008-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79d06aff2fed19d1ff75be93716b07cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abf5c82d258da0a12e68e79a5ca4d8c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4aca233f467a46471fc38bd5821af2d7 |
| publicationDate |
2008-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2211867-T5 |
| titleOfInvention |
USE OF AN ANGIOTENSIN ANTAGONIST (AT1) TO REDUCE POST-INFARITY MORBIDITY AND MORTALITY. |
| abstract |
THE INVENTION REFERS TO A METHOD FOR TREATING A HUMAN SURVIVOR OF AN ATTACK TO THE HEART AND PROVIDES AN ADDITIONAL IMPROVEMENT IN THE SURVIVAL THAT FOLLOWS THE CARDIAC INFARCTION BY THE EARLY INITIATION AND PROLONGED ADMINISTRATION OF AN INITIBORATORY SYSTEM OF ANGIENTENTHENTHYDHE RENTOR SYSTEM CONVERSION OF ANGIOTENSIN CONVERSION. THE INHIBITOR CAN BE USED ON ITSELF, OR IN CONJUNCTION WITH OTHER THERAPEUTIC COMPOUNDS SUCH AS BETA BLOCKERS AND THROMBOTIC AGENTS. THE PREFERRED INHIBITOR IS THE CAPTOPRILE. |
| priorityDate |
1992-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |